← Issue №13/ week of Sep 27, 2026/Pancreas/Biliary

Metastatic pancreatic cancer: from human disease to preclinical modelling.

From GI Signals issue №13: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Pancreas/Biliary review · Sep 24, 2026 · Gut · IF 24.6

Metastatic pancreatic cancer: from human disease to preclinical modelling.

Guideline / reviewpancreatic cancerbasic sciencetranslationalbiomarker
Clinical takeawayNo clinical action yet: a review of preclinical models and mechanisms in pancreatic cancer.
What it foundReview outlines molecular heterogeneity and microenvironment interactions in metastatic PDAC, with no new clinical data reported.
ContextSummarizes current understanding of metastatic PDAC biology but does not challenge or refine clinical practice.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Min J … Maitra A · Gut · IF 24.6 · PubMed ↗Permalink
← Read the whole of issue №13 Every paper GI Signals surfaces gets a page like this one. All issues